Collegium Pharma (COLL) Misses Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Join SI Premium – FREE
Collegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.45), $0.16 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
